Cargando…
The Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study
BACKGROUND: Existing treatments are inadequate for patients at high risk of coronary heart disease caused by elevated levels of plasma low-density lipoprotein cholesterol (LDL-C). Bambuterol is a prodrug of β2-agonist commonly used for the treatment of asthma and chronic obstructive pulmonary diseas...
Autores principales: | Ye, Yanrui, Xu, Hang, Quan, Lei, Zhu, Long, Zeng, Jing, Zhou, Ting, Zou, ChengJuan, Cheng, Qing, Bu, Shujie, Tan, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485901/ https://www.ncbi.nlm.nih.gov/pubmed/26137575 http://dx.doi.org/10.1016/j.ebiom.2015.02.006 |
Ejemplares similares
-
Determination of Montelukast Sodium and Bambuterol Hydrochloride in Tablets using RP HPLC
por: Patil, Smita, et al.
Publicado: (2009) -
Quick simultaneous analysis of bambuterol and montelukast based on synchronous spectrofluorimetric technique
por: El Gamal, Rania, et al.
Publicado: (2020) -
Investigating the Effect of Silver Nanoparticles on the Fluorescence Intensity of Bambuterol and its Active Metabolite Terbutaline Using FRET
por: Abd Elhaleem, Shymaa M., et al.
Publicado: (2023) -
Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
por: Liu, Shijia, et al.
Publicado: (2017) -
Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline
por: Abo El Abass, Samah, et al.
Publicado: (2018)